Results 201 to 210 of about 446,168 (357)

The Effect of Enzymes on Progesterone-Receptor Binding and Chromatin Binding of the Complex in the Estrogen-Primed Rabbit Uterus

, 1978
Teruhiko Tamaya, Norio Furuta, Toshihiko Motoyama, Yousuke Ohono, Shinko Boku, Hiroji Okada   +5 more
openalex   +2 more sources

The lack of relationship between estrogen receptor status and response to chemotherapy [PDF]

, 1980
Russell Hilf, Michael Feldstein, Edwin D. Savlov, Scott L. Gibson, Barbara Seneca   +4 more
openalex   +1 more source

Utilization and expenditure on medicines for the management of osteoporosis in Ireland: A repeated cross‐sectional study

British Journal of Clinical Pharmacology, EarlyView.
Aim Osteoporosis is a prevalent skeletal disease characterized by low bone mass and increased fracture risk. Management of osteoporosis typically involves antiresorptive and anabolic therapies, which are reimbursed in Ireland through various drug schemes.
Amelia Smith, Lisa Kelly, Claire Gorry, Bernard Duggan, Michael Barry   +4 more
wiley   +1 more source

Author Correction: Structural and functional evidence that GPR30 is not a direct estrogen receptor. [PDF]

Cell Res
Liu H, Guo S, Dai A, Xu P, Li X, Huang S, He X, Wu K, Zhang X, Yang D, Xie X, Xu HE.   +11 more
europepmc   +1 more source

Estrogen and progestin receptors in human prostatic carcinoma [PDF]

, 1985
Richard M. Wolf, Sara L. Schneider, J. Edson Pontes, Lenore S. Englander, James P. Karr, Gerald P. Murphy, Avery A. Sandberg   +6 more
openalex   +1 more source

Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study

British Journal of Clinical Pharmacology, EarlyView.
Aims To enhance understanding of betamethasone and its metabolites' pharmacokinetics in pregnancy, specifically early‐onset pre‐eclampsia, through a population pharmacokinetic model. Additionally, to investigate the placental metabolism and transfer of betamethasone and its main metabolites.
Sam Schoenmakers, Letao Li, Anna C. M. Kluivers, Michelle Broekhuizen, Madhavi S. Harhangi, A. H. Jan Danser, Irwin Reiss, Karel Allegaert, Sjoerd A. A. van den Berg, Bertrand D. van Zelst, Ron H. N. van Schaik, Philip L. J. DeKoninck, Emma Ronde, Sebastiaan D. T. Sassen, Sinno H. P. Simons, Birgit C. P. Koch   +15 more
wiley   +1 more source

Phase I study of H3B-6545 in patients with estrogen receptor-positive breast cancer. [PDF]

ESMO Open
Yonemori K, Shimoi T, Yamamoto K, Kogawa T, Kitano S, Kobayashi S, Yanai K, Yamaguchi K, Otake Y, Hojo S, Ono M.   +10 more
europepmc   +1 more source

The tacrolimus concentration‐to‐dose ratio is associated with kidney function in heart transplant recipients

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Heart transplantation (HT) is frequently complicated by chronic kidney disease, of which tacrolimus‐related nephrotoxicity is an important cause. In kidney and liver transplant recipients, fast tacrolimus metabolism (defined as a low concentration‐to‐dose [C0/D] ratio), negatively affects kidney function.
Maaike R. Schagen, Teun B. Petersen, Boris C. A. Seijkens, Jasper J. Brugts, Kadir Caliskan, Alina A. Constantinescu, Brenda C. M. de Winter, Isabella Kardys, Dennis A. Hesselink, Olivier Manintveld   +9 more
wiley   +1 more source

PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells. [PDF]

Discov Oncol
Mo W, Zhang F, Wang C, Ding X, Ren L.
europepmc   +1 more source

Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.

, 1985
Ayako Shimada, Satoshi Kimura, Kaoru Abe, Keisuke Nagasaki, I Adachi, Kazuhiro Yamaguchi, M. Suzuki, Tokuro Nakajima, Larry S. Miller   +8 more
openalex   +1 more source